PC
Puissance Capital Management LP
Concentrated strategyContrarianQuality / disciplined sizing
Total reported value
$17.3M
Reporting period: 2020-09-30 · Number of holdings: 5
Puissance Capital Management LP disclosed 5 holdings in its latest 13F filing for the period ending 2020-09-30, with total reported value of $17.3M and a quarterly turnover rate of 47.6%.
Personality snowflake
- Concentration
- 100
- Portfolio Stability
- 47.65
- Momentum/Contrarian
- 0
- Sector conviction
- 0
- Diversification
- 10
- Sizing Uniformity
- 86.07
Recent moves
Trim EKSOEUR
0.0% -$2.8M
Add BLPHUSD
0.0% -$2.7M
Add CRVS
0.0% $49.0K
Sold out 811292101
New buy SCYXEUR
New buy KDMN
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BLPHUSD | Bellerophon Therapeutics INC | Stock-Other | 67.74% | +5.92% | — | |
| 2 | EKSOEUR | Ekso Bionics Holdings INC | Stock-Other | 21.21% | -6.56% | — | |
| 3 | SCYXEUR | Scynexis INC | Stock-Other | 7.91% | +7.91% | NEW | |
| 4 | KDMN | Kadmon Holdings INC | Stock-Other | 2.27% | +2.27% | NEW | |
| 5 | CRVS | Corvus Pharmaceuticals INC | Stock-Other | 0.88% | +0.44% | — |
Reported value over time
Sector allocation
Not enough sector-mapped data yet
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2020-09-30 | 5 | $17.3M | 48 | |
| 2020-06-30 | 4 | $23.4M | 95 | |
| 2020-03-31 | 6 | $8.6M | 100 | |
| 2019-12-31 | 6 | $40.3M | 54 | |
| 2019-09-30 | 7 | $44.8M | 82 | |
| 2019-06-30 | 7 | $102.2M | 37 | |
| 2019-03-31 | 6 | $123.0M | 40 | |
| 2018-12-31 | 7 | $87.7M | 51 | |
| 2018-09-30 | 5 | $143.3M | 33 | |
| 2018-06-30 | 5 | $133.0M | 14 | |
| 2018-03-31 | 5 | $116.0M | 34 | |
| 2017-12-31 | 4 | $144.8M | 0 |
Holding changes this quarter
Puissance Capital Management LP's most significant position changes for 2020-09-30: Sold out: Scynexis INC Com New; New buy: Scynexis INC (SCYXEUR); New buy: Kadmon Holdings INC (KDMN).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BLPHUSD | Bellerophon Therapeutics INC | +5.9% | — | Unchanged |
| 2 | CRVS | Corvus Pharmaceuticals INC | +0.4% | — | Unchanged |
| 3 | EKSOEUR | Ekso Bionics Holdings INC | -6.6% | — | Unchanged |
| 4 | ✓ | Scynexis INC Com New | — | EXIT | Sold out |
| 5 | SCYXEUR | Scynexis INC | — | NEW | New buy |
| 6 | KDMN | Kadmon Holdings INC | — | NEW | New buy |
FAQ
What is Puissance Capital Management LP and what type of investor is it?
Puissance Capital Management LP is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2020-09-30), the firm manages a tracked equity portfolio valued at approximately $17.3M, spread across 5 disclosed positions.
What are Puissance Capital Management LP's largest equity positions?
Based on the latest 13F filing, Puissance Capital Management LP's top holdings by market value are:
1. Bellerophon Therapeutics INC (BLPHUSD) — $11.7M (67.7%)
2. Ekso Bionics Holdings INC (EKSOEUR) — $3.7M (21.2%)
3. Scynexis INC (SCYXEUR) — $1.4M (7.9%)
4. Kadmon Holdings INC (KDMN) — $393.0K (2.3%)
5. Corvus Pharmaceuticals INC (CRVS) — $152.0K (0.9%)
What changes did Puissance Capital Management LP make in its most recent portfolio filing?
In the latest reported quarter, Puissance Capital Management LP made 3 notable position adjustments: 2 new positions were initiated, 0 existing holdings were added to, 0 positions were partially reduced, and 1 were completely exited. The largest of these moves: Sold out: Scynexis INC Com New; New buy: Scynexis INC (SCYXEUR); New buy: Kadmon Holdings INC (KDMN)
What sectors does Puissance Capital Management LP focus on?
Sector breakdown data is not yet available for Puissance Capital Management LP. Check back after the next 13F processing cycle.